?PROJECT 3: DYNAMIC NETWORKS. Convergent results suggest that distinct age-associated cascades affect separate brain networks. The present project seeks to better understand how pathophysiological compromises affect brain networks and, by doing so, provide insight into measureable network features that can distinguish dysfunction before clinical symptoms emerge. Unlike prior work where we have focused on group-level estimates of static properties of network organization, here we focus on network estimates in individuals including dynamic interactions between networks. We hypothesize the transient coupling between the medial temporal lobe (MTL) and partner cortical systems is critical to normal function and a potential biomarker of dysfunction. The overall goal of this project is to develop within-subject measures of dynamic network interactions and explore their relation to age-associated markers of neurodegeneration. The project exploits recent innovations of the NIH Human Connectome Project (HCP) including acquisition and hardware technology for advanced diffusion imaging.
Aim 1 : To analyze longitudinal data from the HABS cohort to identify, at the level of the subject group, the network topography indicative of preclinical Alzheimer's disease (AD), and distinct from age effects, in subjects with very low levels of A? burden (measured via PIB binding).
Aim 2 : To image a subset of 100 individuals representing a range of A? deposition, assessed by PiB- PET imaging, and Tau deposition, assessed by T807 binding, utilizing a protocol optimized to estimate dynamic interactions among core regions of the MTL network within individuals.
Aim 3 : To explore the relationship of functional network disruption to optimized measures of white matter tract integrity acquired using NIH HCP inspired technology. Of particular focus will be whether evidence of neurodegeneration can be detected in localized white matter tracts concurrent with functional disruption.
Aim 4 : Aggregating data from Aims 2 and 3 and the emerging behavioral data from Project 4, we will explore multivariate relationships between biomarkers of A? and Tau deposition, white-matter disruption, and volume loss, with within-subject estimates of functional network integrity and behavior. !
| Properzi, Michael J; Buckley, Rachel F; Chhatwal, Jasmeer P et al. (2018) Nonlinear Distributional Mapping (NoDiM) for harmonization across amyloid-PET radiotracers. Neuroimage 186:446-454 |
| Hanseeuw, Bernard J; Jonas, Victoria; Jackson, Jonathan et al. (2018) Association of anxiety with subcortical amyloidosis in cognitively normal older adults. Mol Psychiatry : |
| Lee, Catherine; Betensky, Rebecca A; Alzheimer's Disease Neuroimaging Initiative (2018) Time-to-event data with time-varying biomarkers measured only at study entry, with applications to Alzheimer's disease. Stat Med 37:914-932 |
| Jacobs, Heidi I L; Hedden, Trey; Schultz, Aaron P et al. (2018) Structural tract alterations predict downstream tau accumulation in amyloid-positive older individuals. Nat Neurosci 21:424-431 |
| Chiou, Sy Han; Austin, Matthew D; Qian, Jing et al. (2018) Transformation model estimation of survival under dependent truncation and independent censoring. Stat Methods Med Res :962280218817573 |
| Qian, Jing; Chiou, Sy Han; Maye, Jacqueline E et al. (2018) Threshold regression to accommodate a censored covariate. Biometrics : |
| Orlovsky, Irina; Huijbers, Willem; Hanseeuw, Bernard J et al. (2018) The relationship between recall of recently versus remotely encoded famous faces and amyloidosis in clinically normal older adults. Alzheimers Dement (Amst) 10:121-129 |
| Quiroz, Yakeel T; Sperling, Reisa A; Norton, Daniel J et al. (2018) Association Between Amyloid and Tau Accumulation in Young Adults With Autosomal Dominant Alzheimer Disease. JAMA Neurol 75:548-556 |
| Chhatwal, Jasmeer P; Schultz, Aaron P; Johnson, Keith A et al. (2018) Preferential degradation of cognitive networks differentiates Alzheimer's disease from ageing. Brain 141:1486-1500 |
| Hanseeuw, Bernard J; Betensky, Rebecca A; Mormino, Elizabeth C et al. (2018) PET staging of amyloidosis using striatum. Alzheimers Dement 14:1281-1292 |
Showing the most recent 10 out of 170 publications
